The In Vitro Assessments of Antimicrobial Activity multiple award IDV was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to procure microbiology testing services in support of research related to infectious diseases and antimicrobial resistance. Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, received multiple firm fixed price and cost plus fixed fee delivery orders against the contract valued from $14K to $981K to perform such services as determining minimum inhibitory concentrations of candidate antimicrobial products and experimental substances against bacterial pathogens at its North Liberty, Iowa facility. Services also included screening compound libraries for antibacterial activity and analyzing resistance trends over periods of performance from 5 months to 4 years. The National Institute of Allergy and Infectious Diseases aims to enhance understanding of immune-mediated and infectious diseases through its contracted research support services.
JMI Laboratories utilized the multiple award IDV to receive various delivery orders for microbiology testing services including determining minimum inhibitory concentrations of Neisseria gonorrhoeae isolates, experimental antibacterial substances against gram-negative pathogens, and a gram-negative targeted compound collection. Additional services performed under delivery orders were in vitro screening for antibacterial activity against public health pathogens and assessments of antimicrobial activity. Places of performance were in North Liberty, Iowa and values ranged from $159K to $755K over periods of 1 year or less. No set-aside designations were applied to the awards made to JMI Laboratories in support of the National Institute of Allergy and Infectious Diseases' research mission.
Generated 2/3/24, 9:15 AM